A Day Up For Kinnate Biopharma Inc.
Tue, Mar 29, 2022 at 05:30 PM
Kinnate Biopharma Inc. (KNTE:NASDAQ) soared at $13.06, a gain of 25.9%. The stock appeared on our News Catalysts scanner on Mon, Mar 28, 2022 at 05:32 PM in the 'INVESTOR UPDATE' category. From Tue, Mar 15, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
About Kinnate Biopharma Inc. (KNTE:NASDAQ)
Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.
Top 10 Gainers:
- IGM Biosciences, Inc. (IGMS:NASDAQ), 96.73%
- PhaseBio Pharmaceuticals, Inc. (PHAS:NASDAQ), 46.09%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 45.4%
- Oblong Inc. (OBLG:NASDAQ), 45%
- Clever Leaves Holdings Inc. (CLVR:NASDAQ), 40.31%
- MicroVision, Inc. (MVIS:NASDAQ), 32.78%
- ECMOHO Limited (MOHO:NASDAQ), 27.95%
- LianBio (LIAN:NASDAQ), 27.5%
- BBQ Holdings, Inc. (DAVE:NASDAQ), 27.45%
- Kinnate Biopharma Inc. (KNTE:NASDAQ), 25.94%